Regulation and function of endothelial glycocalyx layer in vascular diseases

Vascular Pharmacology

Volumn 100, Issue , 2018, Pages 26-33

  Sieve, Irina ^a   Münster Kühnel, Anja K ^a   Hilfiker Kleiner, Denise ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Endothelium; Glycocalyx; Inflammation; Vascular diseases

Indexed keywords

HEPARANASE; HYALURONIDASE; MATRIX METALLOPROTEINASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SIALIC ACID DERIVATIVE; ANTIINFLAMMATORY AGENT; AUTACOID; CARDIOVASCULAR AGENT;

CARDIOVASCULAR FUNCTION; ENDOTHELIAL SURFACE LAYER; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME DEGRADATION; GLYCOCALYX; INFLAMMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SURFACE PROPERTY; VASCULAR DISEASE; ANIMAL; DRUG EFFECT; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; VASCULAR REMODELING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARDIOVASCULAR AGENTS; ENDOTHELIAL CELLS; GLYCOCALYX; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; SIGNAL TRANSDUCTION; VASCULAR DISEASES; VASCULAR REMODELING;

EID: 85030175723     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2017.09.002     Document Type: Review

References (143)

1. Eberhardt, R.T., Raffetto, J.D., Chronic venous insufficiency. Circulation 111:18 (2005), 2398–2409.
2. Varga, Z.V., Giricz, Z., Liaudet, L., Hasko, G., Ferdinandy, P., Pacher, P., Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim. Biophys. Acta 1852:2 (2015), 232–242.
3. Wang, Y., Song, E., Bai, B., Vanhoutte, P.M., Toll-like receptors mediating vascular malfunction: lessons from receptor subtypes. Pharmacol. Ther. 158 (2016), 91–100.
4. Meng, F., Mambetsariev, I., Tian, Y., Beckham, Y., Meliton, A., Leff, A., Gardel, M.L., Allen, M.J., Birukov, K.G., Birukova, A.A., Attenuation of lipopolysaccharide-induced lung vascular stiffening by lipoxin reduces lung inflammation. Am. J. Respir. Cell Mol. Biol. 52:2 (2015), 152–161.
5. Raffetto, J.D., Mannello, F., Pathophysiology of chronic venous disease. Int. Angiol. 33:3 (2014), 212–221.
6. Cochain, C., Zernecke, A., Macrophages in vascular inflammation and atherosclerosis. Pflugers Arch. 469:3–4 (2017), 485–499.
7. Shirazi, L.F., Bissett, J., Romeo, F., Mehta, J.L., Role of inflammation in heart failure. Curr Atheroscler Rep, 19(6), 2017, 27.
8. Viola, M., Karousou, E., D'Angelo, M.L., Moretto, P., Caon, I., Luca, G., Passi, A., Vigetti, D., Extracellular matrix in atherosclerosis: hyaluronan and proteoglycans insights. Curr. Med. Chem. 23:26 (2016), 2958–2971.
9. Vink, H., Duling, B.R., Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am. J. Physiol. Heart Circ. Physiol. 278:1 (2000), H285–9.
10. Augustin, H.G., Koh, G.Y., Organotypic vasculature: from descriptive heterogeneity to functional pathophysiology. Science, 357(6353), 2017.
11. Cancel, L.M., Ebong, E.E., Mensah, S., Hirschberg, C., Tarbell, J.M., Endothelial glycocalyx, apoptosis and inflammation in an atherosclerotic mouse model. Atherosclerosis 252 (2016), 136–146.
12. Kurzelewski, M., Czarnowska, E., Beresewicz, A., Superoxide- and nitric oxide-derived species mediate endothelial dysfunction, endothelial glycocalyx disruption, and enhanced neutrophil adhesion in the post-ischemic guinea-pig heart. J. Physiol. Pharmacol. 56:2 (2005), 163–178.
13. Wang, L., Huang, X., Kong, G., Xu, H., Li, J., Hao, D., Wang, T., Han, S., Han, C., Sun, Y., Liu, X., Wang, X., Ulinastatin attenuates pulmonary endothelial glycocalyx damage and inhibits endothelial heparanase activity in LPS-induced ARDS. Biochem. Biophys. Res. Commun. 478:2 (2016), 669–675.
14. Leung, W.K., Gao, L., Siu, P.M., Lai, C.W., Diabetic nephropathy and endothelial dysfunction: current and future therapies, and emerging of vascular imaging for preclinical renal-kinetic study. Life Sci. 166 (2016), 121–130.
15. Proteoglycans and sulfated glycosaminoglycans. Esko, J.D., Kimata, K., Lindahl, U., Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., Etzler, M.E., (eds.) Essentials of Glycobiology, 2009, Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY) https://www.ncbi.nlm.nih.gov/books/NBK1908/.
16. Chignalia, A.Z., Yetimakman, F., Christiaans, S.C., Unal, S., Bayrakci, B., Wagener, B.M., Russell, R.T., Kerby, J.D., Pittet, J.F., Dull, R.O., The Glycocalyx and trauma: a review. Shock 45:4 (2016), 338–348.
17. Van Teeffelen, J.W., Brands, J., Stroes, E.S., Vink, H., Endothelial glycocalyx: sweet shield of blood vessels. Trends Cardiovasc. Med. 17:3 (2007), 101–105.
18. Weinbaum, S., Tarbell, J.M., Damiano, E.R., The structure and function of the endothelial glycocalyx layer. Annu. Rev. Biomed. Eng. 9 (2007), 121–167.
19. Curry, F.E., Layer upon layer: the functional consequences of disrupting the glycocalyx-endothelial barrier in vivo and in vitro. Cardiovasc. Res. 113:6 (2017), 559–561.
20. Pries, A.R., Secomb, T.W., Gaehtgens, P., The endothelial surface layer. Pflugers Arch. 440:5 (2000), 653–666.
21. Esko, J.D., Zhang, L., Influence of core protein sequence on glycosaminoglycan assembly. Curr. Opin. Struct. Biol. 6:5 (1996), 663–670.
22. Lennon, F.E., Singleton, P.A., Hyaluronan regulation of vascular integrity. Am. J. Cardiovasc. Dis. 1:3 (2011), 200–213.
23. Curry, F.R., Microvascular solute and water transport. Microcirculation 12:1 (2005), 17–31.
24. Szymczak, M., Kuzniar, J., Klinger, M., The role of heparanase in diseases of the glomeruli. Arch. Immunol. Ther. Exp. 58:1 (2010), 45–56.
25. Florian, J.A., Kosky, J.R., Ainslie, K., Pang, Z., Dull, R.O., Tarbell, J.M., Heparan sulfate proteoglycan is a mechanosensor on endothelial cells. Circ. Res. 93:10 (2003), e136–42.
26. Tarbell, J.M., Pahakis, M.Y., Mechanotransduction and the glycocalyx. J. Intern. Med. 259:4 (2006), 339–350.
27. Yen, W., Cai, B., Yang, J., Zhang, L., Zeng, M., Tarbell, J.M., Fu, B.M., Endothelial surface glycocalyx can regulate flow-induced nitric oxide production in microvessels in vivo. PLoS One, 10(1), 2015, e0117133.
28. Henry, C.B., Duling, B.R., Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am. J. Phys. 277:2 Pt 2 (1999), H508–14.
29. Song, J.W., Zullo, J.A., Liveris, D., Dragovich, M., Zhang, X.F., Goligorsky, M.S., Therapeutic restoration of endothelial glycocalyx in sepsis. J. Pharmacol. Exp. Ther. 361:1 (2017), 115–121.
30. Pries, A.R., Secomb, T.W., Jacobs, H., Sperandio, M., Osterloh, K., Gaehtgens, P., Microvascular blood flow resistance: role of endothelial surface layer. Am. J. Phys. 273:5 Pt 2 (1997), H2272–9.
31. Mulivor, A.W., Lipowsky, H.H., Role of glycocalyx in leukocyte-endothelial cell adhesion. Am. J. Physiol. Heart Circ. Physiol. 283:4 (2002), H1282–91.
32. Henry, C.B., Duling, B.R., TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am. J. Physiol. Heart Circ. Physiol. 279:6 (2000), H2815–23.
33. Larsen, A.M., Leinoe, E.B., Johansson, P.I., Birgens, H., Ostrowski, S.R., High syndecan-1 levels in acute myeloid leukemia are associated with bleeding, thrombocytopathy, endothelial cell damage, and leukocytosis. Leuk. Res. 37:7 (2013), 777–783.
34. Chappell, D., Jacob, M., Hofmann-Kiefer, K., Rehm, M., Welsch, U., Conzen, P., Becker, B.F., Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion. Cardiovasc. Res. 83:2 (2009), 388–396.
35. Nieuwdorp, M., van Haeften, T.W., Gouverneur, M.C., Mooij, H.L., van Lieshout, M.H., Levi, M., Meijers, J.C., Holleman, F., Hoekstra, J.B., Vink, H., Kastelein, J.J., Stroes, E.S., Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 55:2 (2006), 480–486.
36. Burke-Gaffney, A., Evans, T.W., Lest we forget the endothelial glycocalyx in sepsis. Crit. Care, 16(2), 2012, 121.
37. Johansson, P.I., Stensballe, J., Rasmussen, L.S., Ostrowski, S.R., A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann. Surg. 254:2 (2011), 194–200.
38. Rehm, M., Bruegger, D., Christ, F., Conzen, P., Thiel, M., Jacob, M., Chappell, D., Stoeckelhuber, M., Welsch, U., Reichart, B., Peter, K., Becker, B.F., Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 116:17 (2007), 1896–1906.
39. Ramnath, R., Foster, R.R., Qiu, Y., Cope, G., Butler, M.J., Salmon, A.H., Mathieson, P.W., Coward, R.J., Welsh, G.I., Satchell, S.C., Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor alpha: a contributor to endothelial cell glycocalyx dysfunction. FASEB J. 28:11 (2014), 4686–4699.
40. Marechal, X., Favory, R., Joulin, O., Montaigne, D., Hassoun, S., Decoster, B., Zerimech, F., Neviere, R., Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 29:5 (2008), 572–576.
41. Chen, C., Chappell, D., Annecke, T., Conzen, P., Jacob, M., Welsch, U., Zwissler, B., Becker, B.F., Sevoflurane mitigates shedding of hyaluronan from the coronary endothelium, also during ischemia/reperfusion: an ex vivo animal study. Hypoxia (Auckl) 4 (2016), 81–90.
42. Majerczak, J., Grandys, M., Duda, K., Zakrzewska, A., Balcerczyk, A., Kolodziejski, L., Szymoniak-Chochol, D., Smolenski, R.T., Bartosz, G., Chlopicki, S., Zoladz, J.A., Moderate-intensity endurance training improves endothelial glycocalyx layer integrity in healthy young men. Exp. Physiol. 102:1 (2017), 70–85.
43. Nelson, A., Berkestedt, I., Bodelsson, M., Circulating glycosaminoglycan species in septic shock. Acta Anaesthesiol. Scand. 58:1 (2014), 36–43.
44. Neves, F.M., Meneses, G.C., Sousa, N.E., Menezes, R.R., Parahyba, M.C., Martins, A.M., Liborio, A.B., Syndecan-1 in acute decompensated heart failure–association with renal function and mortality. Circ. J. 79:7 (2015), 1511–1519.
45. Dimitrievska, S., Gui, L., Weyers, A., Lin, T., Cai, C., Wu, W., Tuggle, C.T., Sundaram, S., Balestrini, J.L., Slattery, D., Tchouta, L., Kyriakides, T.R., Tarbell, J.M., Linhardt, R.J., Niklason, L.E., New functional tools for antithrombogenic activity assessment of live surface Glycocalyx. Arterioscler. Thromb. Vasc. Biol. 36:9 (2016), 1847–1853.
46. Ebong, E.E., Macaluso, F.P., Spray, D.C., Tarbell, J.M., Imaging the endothelial glycocalyx in vitro by rapid freezing/freeze substitution transmission electron microscopy. Arterioscler. Thromb. Vasc. Biol. 31:8 (2011), 1908–1915.
47. Schmidt, E.P., Yang, Y., Janssen, W.J., Gandjeva, A., Perez, M.J., Barthel, L., Zemans, R.L., Bowman, J.C., Koyanagi, D.E., Yunt, Z.X., Smith, L.P., Cheng, S.S., Overdier, K.H., Thompson, K.R., Geraci, M.W., Douglas, I.S., Pearse, D.B., Tuder, R.M., The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat. Med. 18:8 (2012), 1217–1223.
48. Smith, M.L., Long, D.S., Damiano, E.R., Ley, K., Near-wall micro-PIV reveals a hydrodynamically relevant endothelial surface layer in venules in vivo. Biophys. J. 85:1 (2003), 637–645.
49. Stevens, A.P., Hlady, V., Dull, R.O., Fluorescence correlation spectroscopy can probe albumin dynamics inside lung endothelial glycocalyx. Am. J. Physiol. Lung Cell Mol. Physiol. 293:2 (2007), L328–35.
50. Vlahu, C.A., Lemkes, B.A., Struijk, D.G., Koopman, M.G., Krediet, R.T., Vink, H., Damage of the endothelial glycocalyx in dialysis patients. J. Am. Soc. Nephrol. 23:11 (2012), 1900–1908.
51. Yoon, J.H., Lee, E.S., Jeong, Y., In vivo imaging of the cerebral endothelial glycocalyx in mice. J. Vasc. Res. 54:2 (2017), 59–67.
52. Rubio-Gayosso, I., Platts, S.H., Duling, B.R., Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 290:6 (2006), H2247–56.
53. van Golen, R.F., Reiniers, M.J., Vrisekoop, N., Zuurbier, C.J., Olthof, P.B., van Rheenen, J., van Gulik, T.M., Parsons, B.J., Heger, M., The mechanisms and physiological relevance of glycocalyx degradation in hepatic ischemia/reperfusion injury. Antioxid. Redox Signal. 21:7 (2014), 1098–1118.
54. Pesta, D., Roden, M., The Janus head of oxidative stress in metabolic diseases and during physical exercise. Curr. Diabetes Rep., 17(6), 2017, 41.
55. Fridovich, I., Fundamental aspects of reactive oxygen species, or what's the matter with oxygen?. Ann. N. Y. Acad. Sci. 893 (1999), 13–18.
56. Moseley, R., Waddington, R.J., Embery, G., Degradation of glycosaminoglycans by reactive oxygen species derived from stimulated polymorphonuclear leukocytes. Biochim. Biophys. Acta 1362:2–3 (1997), 221–231.
57. Uchiyama, H., Dobashi, Y., Ohkouchi, K., Nagasawa, K., Chemical change involved in the oxidative reductive depolymerization of hyaluronic acid. J. Biol. Chem. 265:14 (1990), 7753–7759.
58. Soltes, L., Mendichi, R., Kogan, G., Schiller, J., Stankovska, M., Arnhold, J., Degradative action of reactive oxygen species on hyaluronan. Biomacromolecules 7:3 (2006), 659–668.
59. Safrankova, B., Gajdova, S., Kubala, L., The potency of hyaluronan of different molecular weights in the stimulation of blood phagocytes. Mediat. Inflamm., 2010, 2010, 380948.
60. Brown, D.I., Griendling, K.K., Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ. Res. 116:3 (2015), 531–549.
61. Craige, S.M., Kant, S., Keaney, J.F. Jr., Reactive oxygen species in endothelial function - from disease to adaptation. Circ. J. 79:6 (2015), 1145–1155.
62. Vendrov, A.E., Hakim, Z.S., Madamanchi, N.R., Rojas, M., Madamanchi, C., Runge, M.S., Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells. Arterioscler. Thromb. Vasc. Biol. 27:12 (2007), 2714–2721.
63. Sorescu, D., Weiss, D., Lassegue, B., Clempus, R.E., Szocs, K., Sorescu, G.P., Valppu, L., Quinn, M.T., Lambeth, J.D., Vega, J.D., Taylor, W.R., Griendling, K.K., Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105:12 (2002), 1429–1435.
64. Nishino, T., Okamoto, K., Eger, B.T., Pai, E.F., Nishino, T., Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J. 275:13 (2008), 3278–3289.
65. Landmesser, U., Spiekermann, S., Preuss, C., Sorrentino, S., Fischer, D., Manes, C., Mueller, M., Drexler, H., Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease. Arterioscler. Thromb. Vasc. Biol. 27:4 (2007), 943–948.
66. White, C.R., Darley-Usmar, V., Berrington, W.R., McAdams, M., Gore, J.Z., Thompson, J.A., Parks, D.A., Tarpey, M.M., Freeman, B.A., Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc. Natl. Acad. Sci. U. S. A. 93:16 (1996), 8745–8749.
67. Miyoshi, T., Li, Y., Shih, D.M., Wang, X., Laubach, V.E., Matsumoto, A.H., Helm, G.A., Lusis, A.J., Shi, W., Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice. Life Sci. 79:6 (2006), 525–531.
68. Daugherty, A., Dunn, J.L., Rateri, D.L., Heinecke, J.W., Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:1 (1994), 437–444.
69. Sugiyama, S., Okada, Y., Sukhova, G.K., Virmani, R., Heinecke, J.W., Libby, P., Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am. J. Pathol. 158:3 (2001), 879–891.
70. Rajagopalan, S., Meng, X.P., Ramasamy, S., Harrison, D.G., Galis, Z.S., Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest. 98:11 (1996), 2572–2579.
71. Deem, T.L., Cook-Mills, J.M., Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species. Blood 104:8 (2004), 2385–2393.
72. Castro, M.M., Rizzi, E., Figueiredo-Lopes, L., Fernandes, K., Bendhack, L.M., Pitol, D.L., Gerlach, R.F., Tanus-Santos, J.E., Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats. Atherosclerosis 198:2 (2008), 320–331.
73. Hobeika, M.J., Thompson, R.W., Muhs, B.E., Brooks, P.C., Gagne, P.J., Matrix metalloproteinases in peripheral vascular disease. J. Vasc. Surg. 45:4 (2007), 849–857.
74. Fu, X., Kassim, S.Y., Parks, W.C., Heinecke, J.W., Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J. Biol. Chem. 276:44 (2001), 41279–41287.
75. Nagase, H., Woessner, J.F. Jr., Matrix metalloproteinases. J. Biol. Chem. 274:31 (1999), 21491–21494.
76. Grote, K., Flach, I., Luchtefeld, M., Akin, E., Holland, S.M., Drexler, H., Schieffer, B., Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ. Res. 92:11 (2003), e80–6.
77. Chen, Q., Jin, M., Yang, F., Zhu, J., Xiao, Q., Zhang, L., Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediat. Inflamm., 2013, 2013, 928315.
78. Chen, Y., Peng, W., Raffetto, J.D., Khalil, R.A., Matrix metalloproteinases in remodeling of lower extremity veins and chronic venous disease. Prog. Mol. Biol. Transl. Sci. 147 (2017), 267–299.
79. Bruegger, D., Schwartz, L., Chappell, D., Jacob, M., Rehm, M., Vogeser, M., Christ, F., Reichart, B., Becker, B.F., Release of atrial natriuretic peptide precedes shedding of the endothelial glycocalyx equally in patients undergoing on- and off-pump coronary artery bypass surgery. Basic Res. Cardiol. 106:6 (2011), 1111–1121.
80. Jacob, M., Saller, T., Chappell, D., Rehm, M., Welsch, U., Becker, B.F., Physiological levels of A-, B- and C-type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability. Basic Res. Cardiol., 108(3), 2013, 347.
81. Mulivor, A.W., Lipowsky, H.H., Inhibition of glycan shedding and leukocyte-endothelial adhesion in postcapillary venules by suppression of matrixmetalloprotease activity with doxycycline. Microcirculation 16:8 (2009), 657–666.
82. Hsia, K., Yang, M.J., Chen, W.M., Yao, C.L., Lin, C.H., Loong, C.C., Huang, Y.L., Lin, Y.T., Lander, A.D., Lee, H., Lu, J.H., Sphingosine-1-phosphate improves endothelialization with reduction of thrombosis in recellularized human umbilical vein graft by inhibiting syndecan-1 shedding in vitro. Acta Biomater. 51 (2017), 341–350.
83. Bertram, A., Lovric, S., Engel, A., Beese, M., Wyss, K., Hertel, B., Park, J.K., Becker, J.U., Kegel, J., Haller, H., Haubitz, M., Kirsch, T., Circulating ADAM17 level reflects disease activity in proteinase-3 ANCA-associated vasculitis. J. Am. Soc. Nephrol. 26:11 (2015), 2860–2870.
84. Cui, N., Wang, H., Long, Y., Su, L., Liu, D., Dexamethasone suppressed LPS-induced matrix metalloproteinase and its effect on endothelial glycocalyx shedding. Mediat. Inflamm., 2015, 2015, 912726.
85. Gronski, T.J. Jr., Martin, R.L., Kobayashi, D.K., Walsh, B.C., Holman, M.C., Huber, M., Van Wart, H.E., Shapiro, S.D., Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J. Biol. Chem. 272:18 (1997), 12189–12194.
86. Meirovitz, A., Goldberg, R., Binder, A., Rubinstein, A.M., Hermano, E., Elkin, M., Heparanase in inflammation and inflammation-associated cancer. FEBS J. 280:10 (2013), 2307–2319.
87. Chen, S., He, Y., Hu, Z., Lu, S., Yin, X., Ma, X., Lv, C., Jin, G., Heparanase mediates intestinal inflammation and injury in a mouse model of sepsis. J. Histochem. Cytochem. 65:4 (2017), 241–249.
88. Kramer, A., van den Hoven, M., Rops, A., Wijnhoven, T., van den Heuvel, L., Lensen, J., van Kuppevelt, T., van Goor, H., van der Vlag, J., Navis, G., Berden, J.H., Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system. J. Am. Soc. Nephrol. 17:9 (2006), 2513–2520.
89. Rao, G., Ding, H.G., Huang, W., Le, D., Maxhimer, J.B., Oosterhof, A., van Kuppevelt, T., Lum, H., Lewis, E.J., Reddy, V., Prinz, R.A., Xu, X., Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis. Diabetologia 54:6 (2011), 1527–1538.
90. Kumagai, R., Lu, X., Kassab, G.S., Role of glycocalyx in flow-induced production of nitric oxide and reactive oxygen species. Free Radic. Biol. Med. 47:5 (2009), 600–607.
91. Stocker, R., Keaney, J.F. Jr., Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84:4 (2004), 1381–1478.
92. Becker, B.F., Fischer, J., Hartmann, H., Chen, C.C., Sommerhoff, C.P., Tschoep, J., Conzen, P.C., Annecke, T., Inosine, not adenosine, initiates endothelial glycocalyx degradation in cardiac ischemia and hypoxia. Nucleosides Nucleotides Nucleic Acids 30:12 (2011), 1161–1167.
93. Lukasz, A., Hillgruber, C., Oberleithner, H., Kusche-Vihrog, K., Pavenstadt, H., Rovas, A., Hesse, B., Goerge, T., Kumpers, P., Endothelial glycocalyx breakdown is mediated by angiopoietin-2. Cardiovasc. Res. 113:6 (2017), 671–680.
94. Thurston, G., Daly, C., The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway. Cold Spring Harb. Perspect. Med., 2(9), 2012, a006550.
95. Singleton, P.A., Salgia, R., Moreno-Vinasco, L., Moitra, J., Sammani, S., Mirzapoiazova, T., Garcia, J.G., CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin. J. Biol. Chem. 282:42 (2007), 30643–30657.
96. Kucur, M., Karadag, B., Isman, F.K., Ataev, Y., Duman, D., Karadag, N., Ongen, Z., Vural, V.A., Plasma hyaluronidase activity as an indicator of atherosclerosis in patients with coronary artery disease. Bratisl. Lek. Listy 110:1 (2009), 21–26.
97. Riessen, R., Wight, T.N., Pastore, C., Henley, C., Isner, J.M., Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation 93:6 (1996), 1141–1147.
98. McDonald, K.K., Cooper, S., Danielzak, L., Leask, R.L., Glycocalyx degradation induces a proinflammatory phenotype and increased leukocyte adhesion in cultured endothelial cells under flow. PLoS One, 11(12), 2016, e0167576.
99. Chappell, D., Dorfler, N., Jacob, M., Rehm, M., Welsch, U., Conzen, P., Becker, B.F., Glycocalyx protection reduces leukocyte adhesion after ischemia/reperfusion. Shock 34:2 (2010), 133–139.
100. Wrenshall, L.E., Stevens, R.B., Cerra, F.B., Platt, J.L., Modulation of macrophage and B cell function by glycosaminoglycans. J. Leukoc. Biol. 66:3 (1999), 391–400.
101. Yamawaki, H., Hirohata, S., Miyoshi, T., Takahashi, K., Ogawa, H., Shinohata, R., Demircan, K., Kusachi, S., Yamamoto, K., Ninomiya, Y., Hyaluronan receptors involved in cytokine induction in monocytes. Glycobiology 19:1 (2009), 83–92.
102. Docampo, M.J., Cabrera, J., Bassols, A., Hyaluronan mediates the adhesion of porcine peripheral blood mononuclear cells to poly (I:C)-treated intestinal cells and modulates their cytokine production. Vet. Immunol. Immunopathol. 184 (2017), 8–17.
103. Chen, G., Wang, D., Vikramadithyan, R., Yagyu, H., Saxena, U., Pillarisetti, S., Goldberg, I.J., Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression. Biochemistry 43:17 (2004), 4971–4977.
104. Edovitsky, E., Lerner, I., Zcharia, E., Peretz, T., Vlodavsky, I., Elkin, M., Role of endothelial heparanase in delayed-type hypersensitivity. Blood 107:9 (2006), 3609–3616.
105. Friedl, H.P., Till, G.O., Ryan, U.S., Ward, P.A., Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J. 3:13 (1989), 2512–2518.
106. Varki, A., Gagneux, P., Multifarious roles of sialic acids in immunity. Ann. N. Y. Acad. Sci. 1253 (2012), 16–36.
107. Cohen, M., Varki, A., The sialome–far more than the sum of its parts. OMICS 14:4 (2010), 455–464.
108. Schauer, R., Sialic acids as regulators of molecular and cellular interactions. Curr. Opin. Struct. Biol. 19:5 (2009), 507–514.
109. Varki, A., Since there are PAMPs and DAMPs, there must be SAMPs? Glycan “self-associated molecular patterns” dampen innate immunity, but pathogens can mimic them. Glycobiology 21:9 (2011), 1121–1124.
110. Munster, A.K., Eckhardt, M., Potvin, B., Muhlenhoff, M., Stanley, P., Gerardy-Schahn, R., Mammalian cytidine 5′-monophosphate N-acetylneuraminic acid synthetase: a nuclear protein with evolutionarily conserved structural motifs. Proc. Natl. Acad. Sci. U. S. A. 95:16 (1998), 9140–9145.
111. Baumann, A.M., Bakkers, M.J., Buettner, F.F., Hartmann, M., Grove, M., Langereis, M.A., de Groot, R.J., Muhlenhoff, M., 9-O-Acetylation of sialic acids is catalysed by CASD1 via a covalent acetyl-enzyme intermediate. Nat. Commun., 6, 2015, 7673.
112. Harduin-Lepers, A., Vallejo-Ruiz, V., Krzewinski-Recchi, M.A., Samyn-Petit, B., Julien, S., Delannoy, P., The human sialyltransferase family. Biochimie 83:8 (2001), 727–737.
113. Puerta-Guardo, H., Glasner, D.R., Harris, E., Dengue virus NS1 disrupts the endothelial glycocalyx, leading to hyperpermeability. PLoS Pathog., 12(7), 2016, e1005738.
114. Miyagi, T., Yamaguchi, K., Mammalian sialidases: physiological and pathological roles in cellular functions. Glycobiology 22:7 (2012), 880–896.
115. Pshezhetsky, A.V., Ashmarina, L.I., Desialylation of surface receptors as a new dimension in cell signaling. Biochemistry (Mosc) 78:7 (2013), 736–745.
116. Cioffi, D.L., Pandey, S., Alvarez, D.F., Cioffi, E.A., Terminal sialic acids are an important determinant of pulmonary endothelial barrier integrity. Am. J. Physiol. Lung Cell Mol. Physiol. 302:10 (2012), L1067–77.
117. Betteridge, K.B., Arkill, K.P., Neal, C.R., Harper, S.J., Foster, R.R., Satchell, S.C., Bates, D.O., Salmon, A.H.J., Sialic acids regulate microvessel permeability, revealed by novel in vivo studies of endothelial glycocalyx structure and function. J. Physiol. 595:15 (2017), 5015–5035.
118. Zeng, Y., Adamson, R.H., Curry, F.R., Tarbell, J.M., Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding. Am. J. Physiol. Heart Circ. Physiol. 306:3 (2014), H363–72.
119. Betteridge, K., Arkill, K., Neal, C., Harper, S., Foster, B., Satchell, S., Bates, D., Salmon, A., Sialic acids regulate microvessel permeability, revealed by novel in vivo studies of endothelial glycocalyx structure and function. J. Physiol. 595:15 (2017 Aug 1), 5015–5035.
120. Eguchi, H., Ikeda, Y., Ookawara, T., Koyota, S., Fujiwara, N., Honke, K., Wang, P.G., Taniguchi, N., Suzuki, K., Modification of oligosaccharides by reactive oxygen species decreases sialyl lewis x-mediated cell adhesion. Glycobiology 15:11 (2005), 1094–1101.
121. Iijima, R., Takahashi, H., Namme, R., Ikegami, S., Yamazaki, M., Novel biological function of sialic acid (N-acetylneuraminic acid) as a hydrogen peroxide scavenger. FEBS Lett. 561:1–3 (2004), 163–166.
122. Yang, Y., Koo, S., Heng, L.T., Meiselman, H.J., Neu, B., Non-adsorbing macromolecules promote endothelial adhesion of erythrocytes with reduced sialic acids. Biochim. Biophys. Acta 1840:1 (2014), 288–293.
123. Weber, K.S., Alon, R., Klickstein, L.B., Sialylation of ICAM-2 on platelets impairs adhesion of leukocytes via LFA-1 and DC-SIGN. Inflammation 28:4 (2004), 177–188.
124. Sakarya, S., Rifat, S., Zhou, J., Bannerman, D.D., Stamatos, N.M., Cross, A.S., Goldblum, S.E., Mobilization of neutrophil sialidase activity desialylates the pulmonary vascular endothelial surface and increases resting neutrophil adhesion to and migration across the endothelium. Glycobiology 14:6 (2004), 481–494.
125. Orekhov, A.N., Tertov, V.V., Sobenin, I.A., Smirnov, V.N., Via, D.P., Guevara, J. Jr., Gotto, A.M. Jr., Morrisett, J.D., Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J. Lipid Res. 33:6 (1992), 805–817.
126. Harada, L.M., Carvalho, M.D., Passarelli, M., Quintao, E.C., Lipoprotein desialylation simultaneously enhances the cell cholesterol uptake and impairs the reverse cholesterol transport system: in vitro evidences utilizing neuraminidase-treated lipoproteins and mouse peritoneal macrophages. Atherosclerosis 139:1 (1998), 65–75.
127. Mel'nichenko, A.A., Tertov, V.V., Ivanova, O.A., Aksenov, D.V., Sobenin, I.A., Popov, E.V., Kaplun, V.V., Suprun, I.V., Panasenko, O.M., Orekhov, A.N., Desialylation decreases the resistance of apo B-containing lipoproteins to aggregation and increases their atherogenic potential. Bull. Exp. Biol. Med. 140:1 (2005), 51–54.
128. Mochizuki, S., Brassart, B., Hinek, A., Signaling pathways transduced through the elastin receptor facilitate proliferation of arterial smooth muscle cells. J. Biol. Chem. 277:47 (2002), 44854–44863.
129. Görög, P., Pearson, J.D., Sialic acid moieties on surface glycoproteins protect endothelial cells from proteolytic damage. J. Pathol. 146:3 (1985), 205–212.
130. Potter, D.R., Jiang, J., Damiano, E.R., The recovery time course of the endothelial cell glycocalyx in vivo and its implications in vitro. Circ. Res. 104:11 (2009), 1318–1325.
131. van Haare, J., Kooi, M.E., van Teeffelen, J.W., Vink, H., Slenter, J., Cobelens, H., Strijkers, G.J., Koehn, D., Post, M.J., van Bilsen, M., Metformin and sulodexide restore cardiac microvascular perfusion capacity in diet-induced obese rats. Cardiovasc. Diabetol., 16(1), 2017, 47.
132. Kolarova, H., Ambruzova, B., Svihalkova Sindlerova, L., Klinke, A., Kubala, L., Modulation of endothelial glycocalyx structure under inflammatory conditions. Mediat. Inflamm., 2014, 2014, 694312.
133. Schott, U., Solomon, C., Fries, D., Bentzer, P., The endothelial glycocalyx and its disruption, protection and regeneration: a narrative review. Scand. J. Trauma Resusc. Emerg. Med., 24, 2016, 48.
134. Tarbell, J.M., Cancel, L.M., The glycocalyx and its significance in human medicine. J. Intern. Med. 280:1 (2016), 97–113.
135. Ushiyama, A., Kataoka, H., Iijima, T., Glycocalyx and its involvement in clinical pathophysiologies. J. Intensive Care, 4(1), 2016, 59.
136. Becker, B.F., Chappell, D., Bruegger, D., Annecke, T., Jacob, M., Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc. Res. 87:2 (2010), 300–310.
137. Pesonen, E., Keski-Nisula, J., Andersson, S., Palo, R., Salminen, J., Suominen, P.K., High-dose methylprednisolone and endothelial glycocalyx in paediatric heart surgery. Acta Anaesthesiol. Scand. 60:10 (2016), 1386–1394.
138. Broekhuizen, L.N., Lemkes, B.A., Mooij, H.L., Meuwese, M.C., Verberne, H., Holleman, F., Schlingemann, R.O., Nieuwdorp, M., Stroes, E.S., Vink, H., Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia 53:12 (2010), 2646–2655.
139. Achour, A., Kacem, M., Dibej, K., Skhiri, H., Bouraoui, S., El May, M., One year course of oral sulodexide in the management of diabetic nephropathy. J. Nephrol. 18:5 (2005), 568–574.
140. Nieuwdorp, M., Meuwese, M.C., Mooij, H.L., van Lieshout, M.H., Hayden, A., Levi, M., Meijers, J.C., Ince, C., Kastelein, J.J., Vink, H., Stroes, E.S., Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis 202:1 (2009), 296–303.
141. Weiss, R., Niecestro, R., Raz, I., The role of sulodexide in the treatment of diabetic nephropathy. Drugs 67:18 (2007), 2681–2696.
142. Mannello, F., Raffetto, J.D., Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research. Am. J. Transl. Res. 3:2 (2011), 149–158.
143. Coccheri, S., Biological and clinical effects of sulodexide in arterial disorders and diseases. Int. Angiol. 33:3 (2014), 263–274.